Johnson & Johnson (NYSE:JNJ): Current price $79.21
Johnson & Johnson’s Cordis Corporation reported it has completed the purchase of Flexible Stenting Solutions, which develops innovative flexible peripheral arterial, venous, and biliary stents.
The company has announced the opening of the Johnson & Johnson Innovation center in London, representing one of four regional hubs being established in 2013. The goal of the London innovation center is to step up the best early-stage science in the world and to further the development of new healthcare solutions.
Merck anticipates that the U.S. Food and Drug Administration review of its marketing application for an anesthesia-reversal agent should be completed in the second half of 2013, according to Reuters.